Thoma Jeanne

Track

Insider profile

Performance

Overall performance
2.7
Performance over holding periods
4.2
30 days 90 days 120 days
Average return -7% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
3 33% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 93%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Thoma Jeanne's trades of ANI Pharmaceuticals, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
241.43
Quantity 28,701
Value US$1,326,394
Transaction date
Proposed sale
Price
88.87
Quantity 14,675
Value US$1,304,170
Transaction date
Proposed sale
Price
89.76
Quantity 6,865
Value US$616,224
Transaction date
Purchase
Price
46.47
Quantity 1,072 +6.4%
Value US$49,820
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-14 2026-09-11
PlS Planned sale
82,832 -27.7%
231.78
US$1,238,406 		82,832 -27.7% 231.78 US$1,238,406
2026-09-11 2026-09-11
PrS Proposed sale
28,701
241.43
US$1,326,394 		28,701 241.43 US$1,326,394
2025-08-20 2025-08-18
S Sale
42,886 +38.5%
283.87
US$2,907,154 		42,886 +38.5% 283.87 US$2,907,154
2025-08-20 2025-08-18
S Sale
6,865 -15.3%
89.76
US$616,202 		6,865 -15.3% 89.76 US$616,202
2025-08-19 2025-08-18
PrS Proposed sale
14,675
88.87
US$1,304,170 		14,675 88.87 US$1,304,170
2025-08-18 2025-08-18
PrS Proposed sale
6,865
89.76
US$616,224 		6,865 89.76 US$616,224
2021-12-22 2021-12-20
B Purchase
1,072 +6.4%
46.47
US$49,820 		1,072 +6.4% 46.47 US$49,820